Advisor
Dr. Dale Charlton, PhD, is a distinguished biochemist with nearly 40 years of experience spanning the life sciences, pharmaceutical, and biotechnology industries. His career has bridged academia and industry, with early contributions to drug discovery and vaccine immunology, followed by extensive leadership in laboratory and production automation for pharmaceutical fill/finish operations.
Dr. Charlton’s expertise includes:
- EU Compliance and Market Penetration: Advising on regulatory requirements and strategic expansion into European markets.
- Fill/Finish Automation: Providing insights into cutting-edge technologies and trends in final product filling processes.
- Business Development: Offering due diligence for acquisitions, strategic sales support, and identifying new market opportunities.
Highlights from his career include:
- Director of Business Development at Optima Pharma: Led global strategic planning, acquisitions due diligence, and secured over €36 million in project sales.
- Key Account Manager at Hameln Pharmaceuticals: Managed global accounts and cross-selling opportunities.
- Freelance Consultant: Supported companies such as Rychiger AG and MPAC Group with strategic direction, machine development applications, and acquisition assessments.
Dr. Charlton’s academic achievements include earning a PhD in Biochemistry through Pfizer’s Drug Discovery Group and the University of Nottingham. He has authored numerous publications on pharmaceutical automation and served as an industry faculty member for training programs on fill/finish technologies.